Greg Long
About Greg Long
Greg Long is the Executive Director: Head of Oncology Access and Payer Marketing at Bristol-Myers Squibb, with over 20 years of experience in various leadership roles within the company.
Executive Director at Bristol-Myers Squibb
Greg Long is currently serving as the Executive Director: Head of Oncology Access and Payer Marketing at Bristol-Myers Squibb in New Jersey, United States. In this role, he leads initiatives related to oncology access and payer marketing, focusing on strategies to ensure that cancer treatments reach the patients who need them.
Career at Bristol-Myers Squibb
Greg Long has been with Bristol-Myers Squibb since 2000, holding various leadership roles. His notable positions include Director: Payer Marketing for Opdivo and Yervoy from 2012 to 2015, Director: U.S. Pharmaceuticals Market Access Strategy for Oncology and Immunoscience from 2008 to 2012, and Associate Director: U.S. Pharmaceuticals Pricing and Economics from 2005 to 2008. He also served as Senior Manager in Mergers and Acquisitions from 2003 to 2005 and Manager in U.S. Pharmaceuticals Finance from 2002 to 2003.
Educational Background
Greg Long holds a Master of Business Administration (MBA) from London Business School, which he completed in 2000. He also earned another MBA focused on Finance from Cornell Johnson Graduate School of Management between 1998 and 2000. Additionally, he holds a Master of Science from Stanford University, attained in 1994, and a Bachelor of Science in Aerospace Engineering from Cornell University, which he completed in 1993.
Expertise in Payer Marketing
Greg Long has extensive experience in payer marketing, especially for oncology drugs such as Opdivo and Yervoy. His work has involved developing market access strategies that are critical to ensuring these medications are accessible to patients through various payers and insurance systems.
Focus on Market Access Strategy
Throughout his career, Greg Long has played a key role in shaping the market access strategy for oncology and immunoscience products at Bristol-Myers Squibb. His work ensures that innovative pharmaceutical products reach the market efficiently and are accessible to the patients who need them, leveraging his comprehensive understanding of pricing and economics within the pharmaceutical industry.